OMOliver Maier

Oliver Maier

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Oliver Maier has a total of 70 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Inflammatory Type Focal Cerebral Arteriopathy of the Posterior Circulation in Children: A Comparative Cohort Study

    by Nedelina Slavova, Robin Muenger, Iciar Sanchez-Albisua, Maria Regényi, Gabriela Oesch, Joël Fluss, Annette Hackenberg, Sébastien Lebon, Oliver Maier, Alexandre N. Datta, et al.

    BACKGROUND: Inflammatory type focal cerebral arteriopathy (FCA-i) in the anterior circulation (AC) is well characterized, and the focal cerebral arteriopathy severity score (FCASS) reflects the severity of the disease. We identified cases of FCA-i in the posterior circulation (PC) and adapted the FCASS to describe these cases. METHODS: In this comparative cohort study, patients from the Swiss NeuroPaediatric Stroke Registry with ischemic stroke due to FCA-i between January 2000 and December 2018 were analyzed. A comparison between PC and AC cases regarding pediatric National Institutes of Health Stroke Scale score and pediatric stroke outcome measure and FCASS was performed. We estimated infarct size by the modified pediatric Alberta Stroke Program Early Computed Tomography Score in children with AC stroke and the adapted Bernese posterior diffusion–weighted imaging score in the PC. RESULTS: Thirty-five children with a median age of 6.3 (interquartile range, 2.7–8.2 [95% CI, 0.9–15.6]; 20 male; 57.1%) years with FCA-i were identified. The total incidence rate was 0.15/100 000/year (95% CI, 0.11–0.21). Six had PC-FCA-i. Time to final FCASS was longer in the PC compared with AC; the evolution of FCASS did not differ. Initial pediatric National Institutes of Health Stroke Scale score was higher in children with FCA-i in the PC with a median of 10.0 (interquartile range, 5.75–21.0) compared with 4.5 (interquartile range, 2.0–8.0) in those with AC-FCA-i. Different from the anterior cases, PC infarct volume did not correlate with higher discharge, maximum, or final FCASS scores (Pearson correlation coefficient [r], 0.25, 0.35, and 0.54). CONCLUSIONS: FCA-i also affects the PC. These cases should be included in future investigations into FCA-i. Although it did not correlate with clinical outcomes in our cohort, the modified FCASS may well serve as a marker for the evolution of the arteriopathy in posterior FCA-i.


  • Open Access

    Management of Acute Demyelinating Attacks in the Pediatric Population: A Swiss Consensus Statement

    by Seline Hofer, Florian Bauder, Andrea Capone Mori, Andrew Chan, Patricia Dill, Stéphanie Garcia-Tarodo, Barbara Goeggel Simonetti, Annette Hackenberg, Judith Kalser, Oliver Maier, et al.

    Background and methods: Acquired demyelinating syndromes (ADS) encompass distinct entities and occur in approximately 1/100,000 children. While the use of high dose intravenous corticosteroids is well-established, agreement on steroid taper and type of second line therapy is lacking. A comprehensive, unified and standardized treatment approach is crucial in the management of patients with rare diseases. Therefore, this study performed from July 2018 to June 2020 aimed at developing a national consensus on the management of ADS in the pediatric population using the Delphi approach. Consensus was defined as agreement in >75%. Designated Neuropediatricians with an expertise in the management of pediatric neuroinflammatory diseases in all university and cantonal hospitals of Switzerland were included. The response rate was 100%. Results: High-dose i.v. methylprednisolone (20–30 mg/kg/die for 5 days) is the first line treatment irrespective of the distinct entity of the ADS. An oral steroid taper is recommended in acute demyelinating encephalomyelitis (ADEM) and in neuromyelitis optica spectrum disorder (NMO-SD). However, in the latter more in the sense of bridging. The choice of second line treatment depends on the entity of ADS: in optic neuritis (ON) and ADS due to relapsing remitting multiple sclerosis, first line treatment should be repeated, whereas plasma exchange is recommended in NMO-SD, ADEM and transverse myelitis. Conclusions: A national guideline allowing for a more unified approach in the management of pediatric ADS will enhance future research in this field, making data more comparable. The definition of inadequate treatment response to first line therapy remains a challenge and requires future research.


  • Principles and Practice of Child Neurology in Infancy

    by Oliver Maier

    This is the second edition of the book Principles and Practice of Child Neurology, edited by Colin Kennedy and published in 2020 (the first edition was published in 2012). The authors are renowned experts in their field from European centers of child neurology. The concept of a symptom-based approach in the first edition of the book has been maintained with updates to each chapter and with the addition of new topics. The book is written for the pediatric neurologist, whether in training or with several years of experience. It can also provide support to the general pediatrician who wants to obtain a quick overview of neurological topics. In this book, each chapter is introduced with a short text summary of the “key messages,” highlighting “common errors” and “when to worry.” This is very helpful, time saving, and reflects the author's personal experience. The first 13 chapters cover the basics and tools of daily work in pediatric neurology, from neurological examination, neurophysiological methods, cerebral imaging, and genetic studies to pharmacological and nonpharmacological therapeutic principles. A chapter of particular interest in this first part (Chapter 2: “Interprofessional working: user and carer involvement”) deals with interprofessional collaboration in the care of neurologically ill children and adolescents. Here, different concepts related to disability and holistic and family-oriented approaches to it are shown. Another noteworthy and important chapter in this first part is Chapter 4, “Promoting child development.” This chapter emphasizes the importance of external factors, such as the family constellation, economic factors, and education, all of which influence child development. The second part in Chapters 14 to 29 covers symptom-oriented topics in neuropediatrics, including seizures in neonates, childhood and adolescence, birth asphyxia, movement disorder, cerebral palsy, nonepileptic paroxysmal events, and macrocephaly. New or completely revised chapters in this second edition cover microcephaly, floppy infant, stroke, inherited metabolic encephalopathies of infancy, and sleep disorders. The same concept is followed in all the chapters. After providing an overview of the main statements, the topic is explained step by step in a symptom-oriented way in precise and easy-to-read language. New and current topics are included. For example, the chapter “The floppy infant” provides brief information about Spinraza and Zolgensma in the treatment of spinal muscular atrophy. In the chapter on post-neonatal epileptic seizures, the reader receives an update on the current classification of the International League Against Epilepsy (ILAE) and good guidance on the clinical approach for a child with a first epileptic seizure. The various childhood epilepsy syndromes are only briefly mentioned, and epilepsy surgery options are only addressed in a few sentences. However, this is not a negative point; the concept of the book is to provide basic knowledge on the main topics and symptoms in child neurology. For detailed knowledge, one must consult more extensive literature or refer to more comprehensive textbooks. Overall, the second edition of Principles and Practice of Child Neurology in Infancy is an excellent book for a broad readership with an interest in the field of child neurology. The symptom-oriented approach, clear language, well-thought-out didactic concept, and the personal touch and practical knowledge of the renowned authors are convincing. In addition, the European Pediatric Neurology Society (EPNS), together with Mac Keith Press, offers an online course based on this book, which is already available. I congratulate Colin Kennedy and his authors for this excellent book, which effectively reflects the latest developments in the field of child neurology. Publication Date: 26 August 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

  • Open Access

    The Phenotypic Spectrum of PRRT2-Associated Paroxysmal Neurologic Disorders in Childhood

    by Jan Henje Döring, Afshin Saffari, Thomas Bast, Knut Brockmann, Laura Ehrhardt, Walid Fazeli, Wibke G. Janzarik, Gerhard Kluger, Hiltrud Muhle, Rikke S. Møller, et al.

    Pathogenic variants in PRRT2, encoding the proline-rich transmembrane protein 2, have been associated with an evolving spectrum of paroxysmal neurologic disorders. Based on a cohort of children with PRRT2-related infantile epilepsy, this study aimed at delineating the broad clinical spectrum of PRRT2-associated phenotypes in these children and their relatives. Only a few recent larger cohort studies are on record and findings from single reports were not confirmed so far. We collected detailed genetic and phenotypic data of 40 previously unreported patients from 36 families. All patients had benign infantile epilepsy and harbored pathogenic variants in PRRT2 (core cohort). Clinical data of 62 family members were included, comprising a cohort of 102 individuals (extended cohort) with PRRT2-associated neurological disease. Additional phenotypes in the cohort of patients with benign sporadic and familial infantile epilepsy consist of movement disorders with paroxysmal kinesigenic dyskinesia in six patients, infantile-onset movement disorders in 2 of 40 individuals, and episodic ataxia after mild head trauma in one girl with bi-allelic variants in PRRT2. The same girl displayed a focal cortical dysplasia upon brain imaging. Familial hemiplegic migraine and migraine with aura were reported in nine families. A single individual developed epilepsy with continuous spikes and waves during sleep. In addition to known variants, we report the novel variant c.843G>T, p.(Trp281Cys) that co-segregated with benign infantile epilepsy and migraine in one family. Our study highlights the variability of clinical presentations of patients harboring pathogenic PRRT2 variants and expands the associated phenotypic spectrum.


  • Health related quality of life and manual ability 5 years after neonatal ischemic stroke

    by Miriam Caspar-Teuscher, Martina Studer, Maria Regényi, Maja Steinlin, Sebastian Grunt, Sandra Bigi, Andrea Capone Mori, Alexandre Datta, Joel Fluss, Annette Hackenberg, et al.